NCT02841462View on ClinicalTrials.gov

Hydrothermal Ablation in Recurrent and Chronic Symptomatic Bursitis

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

December 31, 2022

Study Completion Date

February 22, 2023

Conditions
Bursitis
Interventions
DEVICE

Intra-bursal thermal ablation

A single 3-minute intra-bursal perfusion of a physiological saline solution at increasing temperatures using the Ablaflex device.

Trial Locations (1)

3320

Vesalius Medical Technologies, Hoegaarden

All Listed Sponsors
lead

Vesalius Medical Technologies

INDUSTRY

NCT02841462 - Hydrothermal Ablation in Recurrent and Chronic Symptomatic Bursitis | Biotech Hunter | Biotech Hunter